Blue Cross of North Carolina lifts co-pays on generics
Raleigh News & Observer, December 31, 2007
Blue Cross and Blue Shield of North Carolina is continuing its strategy to push cheaper drugs. The state's largest health insurer announced Thursday that it will waive co-payments for generic medications used to treat four of the most deadly chronic conditions--congestive heart failure, high blood pressure, high cholesterol and diabetes.
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- 3 Traits Personality Assessments Can't Reveal
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Carondelet to Pay $35M to Settle Fraud Allegations
- Antibiotic Overuse a 'Huge Threat' to Patient Safety, Says CDC
- CHS Hacked, 4.5M Patient Records Compromised